Flu vaccine a Misty promise
FluMist vaccine for influenza is being promoted with big $$$ advertising this year, and at nearly 70 $ per "shot" the flu promises to be hot business. So we should all go down to our friendly pharmacist and sign up for a dose of FluMist - or should we really? It seems the vaccine's major side effects are symptoms of ... the flu!
Dr. Sherri Tenpenny investigated the hype and came to the conclusion that maybe we should be careful of what we put up our nostrils. The brain is quite close, the olfactory nerve connects nose and brain, and it seems the nose may not be the right place to put a virulent mix of bacteria ...
And as we are talking about vaccinations, the risks of another vaccine, the tri-valent MMR (Mumps, Measles and Rubella) variety has been found to be a risky affair as well. The Daily Mail reported recently of new 'compelling' evidence linking the MMR jab to the risk of developing autism.
But first of all, read what Sherri Tenpenny discovered about the new flu vaccine before you make up your mind about this year's flu shot. And would this not be the perfect opportunity for us to show that we can think for ourselves?
October 3, 2003
Risks of FluMist Vaccine
An Investigation By Dr. Sherri Tenpenny
"MedImmune, the manufacturer of FluMist, recently announced that it signed an agreement that makes FluMist, the new intranasal influenza vaccine, readily available to people as they shop at Wal-Mart, the worlds biggest retailer." 
As the physician in charge of a bustling Integrative medical clinic, questions about vaccines frequently arise. After reading about the MedImmune-Walmart joint venture, I felt compelled to warn our patients and our internet subscribers of the potentially serious complications that may come from direct and passive exposure to this new vaccine. I also wanted to give a "heads up" to everyone regarding the onslaught of advertising that is about to besiege them.
Hundreds of TV and print advertisements have been designed to persuade everyone into taking the FluMist plunge. The campaign will be the "most intense, direct-to-consumer marketing campaign ever waged for a vaccine," costing an estimated $25 million over the next 2.5 months . In addition, Wyeth, MedImmunes partner, plans a three-year, $100 million campaign to encourage use of the nasal flu vaccine among physicians.
The television arm of the blitz campaign will focus on the "inconveniences" that your family, friends and co-workers will endure if you dont get the flu shot and subsequently contract the flu. Print advertisements and magazine articles apparently will use scare tactics similar to those that were used while promoting the smallpox vaccine which warned of the high possibility of a "bioterror attack using the flu virus."
Apparently, the goal seems to center around frightening or inducing enough guilt that everyone would begin to demand the vaccine as soon as it is available. And at nearly $70 a dose, this will be a financial bonanza for MedImmune and Wyeth, who are expecting the vaccine to become the blockbuster new drug that will push MedImmunes revenues to more than $1billion/year. 
However, there are many reasons for caution. FluMist contains live (attenuated) influenza viruses that replicate in the nasopharynx of the vaccine recipient. The most common side effects include "cough, runny nose/nasal congestion, irritability, headaches, chills, muscle aches and fever > 100Ă‚Â° F." These symptoms are nearly identical to those the flu vaccine is designed to prevent. 
A cause for significant concern is the vaccines most prevalent side effects: "runny nose" and "nasal congestion." It has been documented that the live viruses from the vaccine can be shed (and potentially spread into the community) from recipient children for up to 21 days, and even longer from adults. Viral shedding also puts breastfeeding infants at risk if the mother has been given FluMist.
In addition to shedding via nasal secretions, the virus can be dispersed through sneezing. What is the normal physiological response when an irritant enters the nasal passages? A sneeze&sometimes a big sneeze&sometimes several big sneezes. Therefore, the risk for shedding and spreading live viruses throughout a school, church, workplace, or store especially one which is administering the vaccine.
In the section of the FluMist package insert labeled "PRECAUTIONS," the manufacturer states the following warning:
"FluMistĂ‚® recipients should avoid close contact with immunocompromised individuals for at least 21 days."
The warning is specifically directed toward those living in the same household with an immunocompromised person, but the on-going release of live viruses throughout the community may be a significant risk to everyone who has a weak, or weakened, immune system.
The number of immunocompromised people in the United States is enormous:
- It is estimated that at least 10%, or more than 28 million people have eczema. 
- More than 8.5 million people have cancer. 
- There are reported to be 850,000 individuals with diagnosed and undiagnosed HIV infection or AIDS  and
- Based on 2001 data, there were 184,000 organ recipients 
An even more extensive list of at-risk people includes the untold millions on drugs called corticosteroids. PrednisoneĂ‚®, MedrolĂ‚®, and a variety of similar medications are given to both adults and children. These drugs are prescribed for dozens of conditions including asthma; allergies; eczema; emphysema; Crohns disease; multiple sclerosis; herniated spinal discs; acute muscular pain syndromes; and all types of rheumatoid and autoimmune diseases. As much as 60% of the entire population could be considered to be "chemically immunosuppressed." It is important to realize that FluMist is CONTRAINDICATED for people who are immunocompromised. People who receive FluMist and are living with an immunocompromised person put their loved ones at risk.
Will this make stores that administer the vaccines like Walmart and the other pharmaceutical chain stores that have announced they will carry FluMist  risky places to shop for large segments of the population? What measures will be taken in these stores to ensure that the virus will not become commingled with food? What hand washing policy is going to be enforced in the stores for all Walmart employees and customers who have received FluMist? These are reasonable questions that deserve answers.
The target market for FluMist is "healthy children and adults, ages 5 to 49 yrs." Some believe that by vaccinating these people, a type of "herd immunity" will occur that will protect the very young and the elderly who are excluded from getting this vaccine. However, it is these very "at-risk" populations who may suffer the most from the flu by being exposed to people who are given FluMist.
According to information presented at the May, 2003 National Influenza Summit, approximately 85% of Americans between the ages of 20 and 50 go unvaccinated, and nearly 66% between the ages of 50 and 64 do not receive the flu vaccine. Have there been "raging epidemics" across the country due to lack of flu vaccinations? It appears that the massive campaign to vaccinate everyone this year appears may be motivated, in part, by economics.
The viruses suspected to be the most likely cause for the flu this season were negligibly different from the strains used in last years flu vaccine. Therefore, the influenza vaccine produced for the 2003-2004 season is identical in composition to the one used last year. This marks only the second time that the same strains have been used during two consecutive flu seasons. Consider that antibodies from other viral vaccines such as MMR, polio and chickenpox vaccines last at least 3 years, and in some instances, up to 15 years. If the viruses used in the vaccine are the same as last year, why is this years vaccine even necessary?
An ever greater concern about FluMist is the contents within the vaccine. Each 0.5ml of the formula contains 10 6.5-7.5 particles of live, attenuated influenza virus. That means that between 10 million and 100 million viral particles will be forcefully injected into the nostrils when administered. The viral strain was developed by serial passage through "specific pathogen-free primary chick kidney cells" and then grown in "specific pathogen-free eggs." That means that the culture media was free of pathogens that were specifically tested for, but not a culture that was necessarily "pathogen-free." The risk that the vaccine may contain contaminant avian retroviruses still remains. In addition, a stabilizing buffer containing potassium phosphate, sucrose (table sugar) and nearly 0.5 mg of monosodium glutamate (MSG) is added to each dose. 
One of the most troubling concerns over the injection of this "chemical soup" is the potential for the viruses to enter directly into the brain. At the top of the nasal passages is a paper-thin bone called the cribriform plate. The olfactory nerves pass through this bone and line the nasal passages, carrying messenger molecules to the brain that are identified as "smells" familiar to us. The olfactory tract has long been recognized as a direct pathway to the brain. Intranasal injection of certain viruses has resulted in a serious brain infection called encephalitis, presumably by direct infection of the olfactory neurons that carried the viruses to the brain. Time will tell whether the live viruses in FluMist will become linked to cases of encephalitis.
The pharmaceutical companies do not necessarily always do a reasonable job of considering the "down side" when they are pushing new drugs or new vaccines. FluMist has the potential for causing the worst, most severe flu epidemic seen in years. Parents tell their young children not to put things up their noses because they might cause them harm. It would be wise to consider that advice for adults. With all the risks involved, one should be extremely cautious about what one allows to be sprayed in ones nose.
1] DowJones Business News. Sept. 12, 2003. FluMist Available In Pharmacies This Fall.
2] Washington Post. Nasal spray for flu to get big media launch. Sept. 10, 2003, pg. E01
3] Washington Post. Spray vaccine for flu wins FDA clearance. June 18, 2003. pg. A01.
4] Mohammed, Madjid. Influenza as a bioweapon. J.R.Soc.Med. 2003;96:345-346.
5] Adler, Neil. MedImmune awaits the $1 billion mark and a new flu drug. The Business Gazette. Feb. 7, 2003.
6] FluMist package insert.
7] Vesikari T., et al. A randomized, double-blind, placebo-controlledtrial of the safety, transmissibility and phenotypic stability of a live, attenuated, cold-adapted influenza virus vaccine (CAIV-T) in children attending day care. Presented at the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, (Chicago, IL). 2001
8] ibid. (Chicago, IL). 2001
9] Zangwell, Kenneth. Cold-adapted, live attenuated intranasal influenza virus vaccine. The Pediatric Infectious Disease
Journal 2003; 22(3):273-274.
10] Drug information. http://www.nlm.nih.gov
11] Diepgen TL. Is the prevalence of atopic dermatitis increasing? In: Williams HC, ed. Atopic Dermatitis: The Epidemiology, Causes and Prevention of Atopic Eczema. New York: Cambridge Univ Pr; 2000:96-112.
12] National Cancer Institute. CanQues. Available at http://srab.cancer.gov/ . Accessed January 3, 2002.
13] Joint United Nations Programme on HIV/AIDS. Epidemiological Fact Sheets on HIV and Sexually Transmitted Infections: United States. Available at http://www.unaids.org. Accessed January 14, 2002
14] United Network for Organ Sharing (UNOS). All Recipients: Age at Time of Transplant. Available at http://www.unos.org. Accessed January 14, 2002.
15] Allan and Harold Rubin, MS, ABD, CRC. September 26, 2003. Vaccinations and the Elderly. http://www.therubins.com
16] May 20-21, 2003, the National Influenza Summit. Chicago, IL. http://www.partnersforimmunization.org
18] FluMist package insert.
19] Knipe, David. M. Ed. Fields Virology. Philadelpthis: Lippincott, 4th ed. 2001. pg. 1057
"... if an individual has five consecutive flu shots his or her chances of developing Alzheimer's Disease are 10 times greater than if they had one, two or no shots..."
Flu Vaccinations (from June Russell's Health Facts)
Video: H5N1 DNA in Flu Vaccine?
Flu Mist over the counter live flu vaccine has been found to contain two H5N1 DNA markers, these markers seem to have been sewn into the flu mist vaccine to ensure that H5N1 or another strain of Avian Flu goes pandemic.
posted by Sepp Hasslberger on Tuesday October 7 2003
updated on Sunday July 6 2008
URL of this article:
CDC, Media Hype The Flu - Facts Show Different Picture
Vaccine maker Chiron had their license suspended and a year's worth of flu vaccines produced in a British factory was not approved for sale in the US - contamination problems. The media treated us to stories of seniors standing in line for hours to "get the flu shot". What they did not say was that the flu is nowhere near as dangerous as they told us previously. Who has not... [read more]
November 06, 2004 - Sepp Hasslberger
Better Than A Flu Shot - Vitamin C Does The Trick
The flu season is upon us another time with a vengeance. This year, we have a special propaganda bonus - the bird flu - although it has very little to do with the flu that gives us the sniffles in any normal year. There is no vaccine for the bird flu because it is a bird virus that "has not yet mutated to be transmitted between humans" but we are... [read more]
November 14, 2005 - Sepp Hasslberger
Flu shots - how useful are they?
With 6300 cases of influenza so far and a reported six flu related deaths in Colorado, US health officials say that "this could be an especially bad flu season nationwide, with some parts of the country — particularly Colorado, Texas and Nevada — hit hard a month earlier than usual", as reported by AP. How to prepare for the eventuality of catching the bug? Or better yet - how to... [read more]
December 04, 2003 - Sepp Hasslberger
Bird Flu Scare - 'Handsome Profit' For Rumsfeld
That the flu scare is a pharmaceutical cash-cow cannot really be disputed. Why can't I be surprised to read that Donald Rumsfeld, Bush II's Defense Secretary, already well known by the more health conscious among us for his role in approving deadly aspartame for human consumption, is implicated directly in this one as well? Dr Mercola has been the target of unpleasant legal attention by the aspartame makers for his... [read more]
October 20, 2005 - Sepp Hasslberger
Flu Mist anyone?
As the press tells us that flu vaccines are running low all over the United States, there is some talk of using the newly developed "Flu Mist" preparation, which differs from the usual influenza vaccines in two ways. First of all, it does not require a needle to administer but is sprayed right into the nasal cavity. Secondly, it contains not dead but live strains of virus and apparently not... [read more]
December 11, 2003 - Sepp Hasslberger
Flu Experts: Vaccine Effectiveness 'not demonstrated'
After telling us to get our flu shots this past season, flu experts are now admitting that they could not - and still can not - predict what strain of the virus will be predominant in any coming season. So composing the vaccine is somewhat like trying to hit the winning lottery ticket. "We were unable to demonstrate vaccine effectiveness against influenza-like illness," said the CDC's Dr. Carolyn Bridges, who... [read more]
February 19, 2004 - Sepp Hasslberger